Vallon Pharmaceuticals Inc Ordinary Shares (NASDAQ:VLON)

North American company
add to virtual portfolio
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - VLON

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - VLON

  • Market Cap$34.750m
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINUS92023M1018

Company Profile

Vallon Pharmaceuticals Inc is a biopharmaceutical company primarily focused on the development and commercialization of proprietary biopharmaceutical products. The company develops prescription drugs for central nervous system disorders. Its product ADAIR, a proprietary, abuse-deterrent oral formulation of immediate-release dextroamphetamine for the treatment of attention-deficit/hyperactivity disorder, and narcolepsy.

Latest VLON news

Currently there for this company. Visit our news hub for other news .